2C-B-FLY (1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b'] difuran-4-yl)-2-aminoethane) is an Unscheduled Research Chemical, that is not approved for human consumption, in the United States. It is a gray area in the law because it may be illegal and covered under the analog act.
Addictive Potential: Unknown
Emergency Room Visits Yearly: No recorded hospital visits
Mandatory Minimum Sentence: Unknown
Mechanism of Action: 5-HT(2A) receptor agonist
2C-B-FLY is a psychedelic phenethylamine of the 2C family. Alexander Shulgin lists the dosage of 2C-B-FLY at 10 mg orally (Shulgin, 2004). It is reported to produce psychedelic effects that last 6-8 hours, or up to 12 hours in larger doses.
At present, none of the FLY compounds are formally controlled in the United States. However, their core structures are highly similar to the Schedule I hallucinogens 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and 4-bromo-2,5-dimethoxyamphetamine (DOB). For this reason, they could potentially be prosecuted under the tenets of the Controlled Substances Analogue Enforcement Act.
Side Effects and Adverse Reactions:
2C-B-FLY is a research chemical. Research chemicals are experimental chemicals that are not approved for human consumption. This is because not enough data exists currently about their side effects, adverse reactions, long term damage, addiction potential, etc. Although some people are willing to ingest research chemicals, it is not reasonable to assume that they are in any way safe to use recreationally.
There have been some recent deaths and hospitalizations associated with 2C-B-FLY. According to Erowid, “Tainted or mislabeled 2C-B-Fly may have contributed to more than one death in early October 2009. One death in Denmark was reportedly related to a batch labeled “b1″ on the packaging. A second death and additional hospitalizations have been reported but not yet confirmed.”
Deaths from 2-C-B-Fly